Salomon & Ludwin’s ResMed RMD Stock Holding History

Salomon & Ludwin’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-54	Closed	-$13.2K	–	2172
2025 Q4	$13.2K	Buy	+54	New	+$13.8K	﹤0.01%	1231

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Salomon & Ludwin's RMD Position: Q1 2026 in Review

Salomon & Ludwin sold out of ResMed (RMD) in Q1 2026, closing a stake of 54 shares — an estimated $13.2K sold.

Salomon & Ludwin first reported a position in RMD in Q4 2025 and held it in 1 quarter. The position peaked at $13.2K in Q4 2025. 941 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Salomon & Ludwin reported no remaining ResMed position as of Q1 2026 after selling out during the quarter.
Salomon & Ludwin sold 54 ResMed shares in Q1 2026, an estimated $13.2K.
Salomon & Ludwin first reported a position in ResMed in Q4 2025 and held it in 1 quarter.
Salomon & Ludwin's ResMed position peaked at $13.2K in Q4 2025.
941 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.